heiBIB: Merx, Kirsten

Merx, Kirsten Dr. med.Universität HeidelbergHeidelberg

Publikationsliste einschränken

Publikationsjahre

Publikationstypen

Liste

Sprache

englisch (33)
deutsch (3)

Co-Autoren (Uni Heidelberg)

mehr ...

Co-Autoren (extern)

mehr ...

Publikationen in heiBIB

Bugia, Luis: Nivolumab as a promising treatment option for metastatic salivary duct carcinoma / Luis Bugia, Frederic Jungbauer, Lena Zaubitzer, Christian Hörner, Kirsten Merx, Abo-Madyan Yasser, T… , September 2024. - 5 S. : Illustrationen
In: Journal of immunotherapy, ISSN 1537-4513. 47(2024), 7, Seite 258-262
DOI: 10.1097/CJI.0000000000000513
Hofheinz, Ralf-Dieter: mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer : a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) / R.-D. Hofheinz, F. Herrle, T. Dechow, L.F. von Weikersthal, M. Welslau, S. Lettmaier, C. Burkart, S.… , September 2024. - 9 S. : Illustrationen
In: ESMO open, ISSN 2059-7029. 9(2024), 9 vom: Nov., Artikel-ID 103703, Seite 1-9
DOI: 10.1016/j.esmoop.2024.103703
Hohneck, Anna: Hemodynamic and stress response after sound intervention with different headphone systems : a double-blind randomized study in healthy volunteers working in the health care sector / Anna Hohneck, Christina Reyser, Rimma Usselmann, Lara Heinemann, Simone Weingaertner, Hardy Reckling… , 4 April 2024. - 11 S.
In: Journal of integrative and complementary medicine, ISSN 2768-3613. 30(2024), 4, Seite 360-370
DOI: 10.1089/jicm.2022.0757
Jungbauer, Frederic: Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies : a single center study / Frederic Jungbauer, Annette Affolter, Christoph Brochhausen, Anne Lammert, Sonja Ludwig, Kirsten Mer… , 14 February 2024. - 13 S.
In: Frontiers in oncology, ISSN 2234-943X. 14(2024) vom: Feb., Artikel-ID 1287178, Seite 1-13
DOI: 10.3389/fonc.2024.1287178
Hohmann, Laura: Assessment and evaluation of psychosocial distress in outpatients with cancer at a University Hospital in Germany / Laura Hohmann, Kirsten Merx, Simone Weingärtner, Annette Schreiber, Svetlana Hetjens, Wolf-Karsten H… . -
Freiburg: S. Karger Verlag für Medien und Naturwissenschaften GmbH, 2023. - 1 Online-Ressource (9 Seiten) : Illustration
DOI: 10.11588/heidok.00035688
Hohmann, Laura: Assessment and evaluation of psychosocial distress in outpatients with cancer at a university hospital in Germany : research article / Laura Hohmann, Kirsten Merx, Simone Weingaertner, Annette Schreiber, Svetlana Hetjens, Wolf-Karsten … , October 2023. - 9 S.
In: Oncology research and treatment, ISSN 2296-5262. 46(2023), 10 vom: Okt., Seite 426-434
DOI: 10.1159/000531888
Hohneck, Anna: Effects of a sound intervention on physical and emotional well-being in patients with cancer : a prospective randomized trial / Anna Hohneck, Rosa Meissner, Christina Reyser, Lara Heinemann, Kathrin Christians, Kirsten Merx, Sim… , February 2023. - 10 S. : Illustrationen
In: Oncology research and treatment, ISSN 2296-5262. 46(2023), 1/2, Seite 1-10
DOI: 10.1159/000528187
Burger, Ralph: Immuntherapien in der Uroonkologie : Ansprechen und Therapieunterbrechungen durch Nebenwirkungen in einer bizentrischen Real-world-Analyse : Originalien / Ralph Burger, Jonas Jarczyk, Niklas Westhoff, Thomas S. Worst, Jonas Herrmann, Kirsten Merx, Anja We… , 09 March 2022. - 8 S.
In: Die Urologie, ISSN 2731-7072. 61(2022), 7, Seite 759-766
DOI: 10.1007/s00120-022-01793-9
Hofheinz, Ralf-Dieter: FLOT versus FLOT/Trastuzumab/Pertuzumab perioperative therapy of human epidermal growth factor receptor 2-positive resectable esophagogastric adenocarcinoma : a randomized phase II trial of the AIO EGA study group / Ralf-Dieter Hofheinz, Kirsten Merx, Georg M. Haag, Christoph Springfeld, Thomas Ettrich, Kersten Bor… , June 16, 2022. - 12 S.
In: Journal of clinical oncology, ISSN 1527-7755. 40(2022), 32, Seite 3750-3761
DOI: 10.1200/JCO.22.00380
Deutsche Krebsgesellschaft / Arbeitsgemeinschaft für Internistische Onkologie: Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma : a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group / Ralf-Dieter Hofheinz, Susanne Hegewisch-Becker, Volker Kunzmann, Peter Thuss-Patience, Martin Fuchs,… , 2021. - 11 S.
In: International journal of cancer, ISSN 1097-0215. 149(2021), 6, Seite 1322-1331
DOI: 10.1002/ijc.33696
Hohneck, Anna: Differential effects of sound intervention and rest on cardiovascular parameters in cancer patients : a randomized cross-over trial / Anna Hohneck, Christina Reyser, Kirsten Merx, Simone Weingärtner, Athanasios Mavratzas, Gerhard Schu… , April 5, 2021. - 12 S.
In: Integrative cancer therapies, ISSN 1552-695X. 20(2021), Artikel-ID 1534735421995239, Seite 1-12
DOI: 10.1177/1534735421995239
Hirsch, Daniela: Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system / Daniela Hirsch, Timo Gaiser, Kirsten Merx, Simone Weingaertner, Michael Forster, Alexander Hendricks… , 2020. - 11 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 147(2021), 1, Seite 263-273
DOI: 10.1007/s00432-020-03335-2
Gaiser, Maria: Evaluation of EGFR inhibitor-mediated acneiform skin toxicity within the double-blind randomized EVITA trial : A thorough gender-specific analysis using the WoMo score / Maria R. Gaiser, Sylvie Lorenzen, Kirsten Merx, Jörg Trojan, Janja Ocvirk, Thomas J. Ettrich, Salah-… , 14 June 2019. - 7 S.
In: Retrospektive Datenauswertung des Tumorregisters Würzburg im Zeitraum 2005 – 2013 bei Patienten mit Nicht-Kleinzelligem-Bronchialkarzinom (NSCLC) mit besonderer Betrachtung der Tyrosinkinaseinhibitor-Therapie bei EGFR-Mutation. 8(2019), 9, Seite 4169-4175
DOI: 10.1002/cam4.2132
Galata, Christian: Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation : a cohort study from a tertiary referral hospital / Christian Galata, Kirsten Merx, Sabine Mai, Timo Gaiser, Frederik Wenz, Stefan Post, Peter Kienle, R… , 02 August 2018. - 8 S.
In: World journal of surgical oncology, ISSN 1477-7819. 16(2018), Artikel-ID 156, Seite 1-8
DOI: 10.1186/s12957-018-1455-x
Gaiser, Maria: Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women : a post hoc analysis of the EVITA trial / M.R. Gaiser, S. Lorenzen, K. Merx, J. Trojan, J. Ocvirk, T.J. Ettrich, S.-E. Al-Batran, H. Schulz, N… , 11 October 2018. - 3 S.
In: Annals of oncology, ISSN 1569-8041. 29(2018), 12, Seite 2393-2395
DOI: 10.1093/annonc/mdy451
Vogel, Arndt: PICCA study : panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer$da randomised biomarker-driven clinical phase II AIO study / Arndt Vogel, Stefan Kasper, Michael Bitzer, Andreas Block, Marianne Sinn, Henning Schulze-Bergkamen,… , 3 February 2018. - 9 S.
In: European journal of cancer, ISSN 1879-0852. 92(2018), Seite 11-19
DOI: 10.1016/j.ejca.2017.12.028
Wein, Axel: Weekly high-dose 5-fluorouracil as 24-hour infusion combined with sodium folinic acid (AIO regimen) plus irinotecan in second-line and sequential therapy of metastatic colorectal cancer (CRC) / Axel Wein, Juergen Siebler, Kerstin Wolff, Nicola Ostermeier, Dagmar Busse, Alexander Hagel, Franz K… , July 2017. - 9 S.
In: Anticancer research, ISSN 1791-7530. 37(2017), 7, Seite 3771-3779
DOI: 10.21873/anticanres.11752
Merx, Kirsten: Panitumumab in combination with preoperative radiation therapy in patients with locally advanced RAS wild-type rectal cancer : results of the multicenter explorative single-arm phase 2 study NEORIT / Kirsten Merx, MD, Uwe M. Martens, MD, Melanie Kripp, MD, Thomas Hoehler, MD, Michael Geissler, MD, T… , 28 Juni 2017. - 9 S.
In: International journal of radiation oncology, biology, physics, ISSN 1879-355X. 99(2017), 4, Seite 867-875
DOI: 10.1016/j.ijrobp.2017.06.2460
Merx, Kirsten: Trastuzumab in esophagogastric cancer : HER2-testing and treatment reality outside clinical studies in Germany / Kirsten Merx, Manuel Barreto Miranda, Lenka Kellermann, Ulrich Mahlknecht, Oliver Lange, Michael Gon… , 2016. - 7 S.
In: Gastroenterology research and practice, ISSN 1687-630X. (2016) Artikel-Nummer 1028505, 7 Seiten
Kripp, Melanie: Prognostic impact of mRNA expression levels of HER1-4 (ERBB1-4) in patients with locally advanced rectal cancer / Melanie Kripp, Kirsten Merx, Ralph Markus Wirtz, Timo Gaiser, Sebastian Eidt, Juliana Schwaab, Stefa… , 2016. - 9 S.
In: Gastroenterology research and practice, ISSN 1687-630X. (2016) Artikel-Nummer 3481578, 9 Seiten
DOI: 10.1155/2016/3481578
Kripp, Melanie: Does physical activity improve quality of life in cancer patients undergoing chemotherapy? / Melanie Kripp, Anna-Lena Heußer, Sebastian Belle, Axel Gerhardt, Kirsten Merx, Wolf-Karsten Hofmann,… . -
Basel: Karger, 24 Okt. 2019. - 1 Online-Ressource (6 Seiten)
DOI: 10.11588/heidok.00027246
Kripp, Melanie: Does physical activity improve quality of life in cancer patients undergoing chemotherapy? / Melanie Kripp, Anna-Lena Heußer, Sebastian Belle, Axel Gerhardt, Kirsten Merx, Wolf-Karsten Hofmann,… , May 04, 2015. - 6 S.
In: Oncology research and treatment, ISSN 2296-5262. 38(2015), 5, Seite 230-236
DOI: 10.1159/000381734
Kripp, Melanie: Does the addition of cetuximab to radiochemotherapy improve outcome of patients with locally advanced rectal cancer? : long-term results from phase II trials / M. Kripp, K. Horisberger, S. Mai, P. Kienle, T. Gaiser, S. Post, F. Wenz, K. Merx, R.-D. Hofheinz, 2015. - 9 S.
In: Gastroenterology research and practice, ISSN 1687-630X. (2015) Artikel-Nummer e273489, 9 Seiten
DOI: 10.1155/2015/273489
Barreto Miranda, Manuel: Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer : a multicenter phase II study / Manuel Barreto Miranda, Jörg Thomas Hartmann, Salah-Eddin Al-Batran, Melanie Kripp, Deniz Gencer, An… , May 2014. - 9 S.
In: Journal of cancer research and clinical oncology, ISSN 1432-1335. 140(2014), 5, Seite 829-837
DOI: 10.1007/s00432-014-1619-1
Hubert, Elisabeth: Cancer patients and advance directives : a survey of patients in a hematology and oncology outpatient clinic / Hubert, Elisabeth; Schulte, Nadine; Belle, Sebastian; Gerhardt, Axel; Merx, Kirsten; Hofmann, Wolf-K… , 2013. - 5 S.
In: Onkologie, ISSN 1423-0240. 36(2013), 7-8, Seite 398-402
DOI: 10.1159/000353604
Merx, Kirsten: Effects of imatinib mesylate in patients with polycythemia vera : results of a phase II study / Merx, Kirsten; Fabarius, Alice; Erben, Philipp ... Reiter, Andreas; Hofmann, Wolf-Karsten; Hehlmann,… , 2013. - 9 S.
In: Annals of hematology, ISSN 0939-5555. 92(2013), 7, Seite 907-915
Lengfelder, Eva: Diagnosis and therapy of polycythemia vera / Eva Lengfelder, Kirsten Merx, Rüdiger Hehlmann, 02. Mai 2006. - 9 S.
In: Seminars in thrombosis and hemostasis, ISSN 1098-9064. 32(2006), 3, Seite 267-275
DOI: 10.1055/s-2006-939438
Lahaye, Tanja: Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center / Tanja Lahaye, Birte Riehm, Ute Berger, Peter Paschka, Martin C. Müller, Sebastian Kreil, Kirsten Mer… , 03 March 2005. - 11 S.
In: Cancer, ISSN 1097-0142. 103(2005), 8, Seite 1659-1669
DOI: 10.1002/cncr.20922
Müller, Martin Christian: Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia / Martin C. Müller, Tanja Hördt, Peter Paschka, Kirsten Merx, Paul La Rosée, Rüdiger Hehlmann, Andreas… , May 2004. - 4 S.
In: Acta haematologica, ISSN 1421-9662. 112(2004), 1-2, Seite 30-33
DOI: 10.1159/000077557
Paschka, Peter: Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission / P. Paschka, M.C. Müller, K. Merx, S. Kreil, C. Schoch, T. Lahaye, A. Weisser, A. Petzold, H. König, … , 10 September 2003. - 8 S.
In: Leukemia, ISSN 1476-5551. 17(2003), 9, Seite 1687-1694
DOI: 10.1038/sj.leu.2403033
Müller, Martin Christian: Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C / M. C. Müller, N. Gattermann, T. Lahaye, M. W. N. Deininger, A. Berndt, S. Fruehauf, A. Neubauer, T. … , 02 October 2003. - 9 S.
In: Leukemia, ISSN 1476-5551. 17(2003), 12, Seite 2392-2400
DOI: 10.1038/sj.leu.2403157
Hochhaus, Andreas: Aktuelle Therapiekonzepte bei chronischer myeloischer Leukämie : Die Studie IV der Deutschen CML-Studiengruppe / A. Hochhaus, U. Berger, A. Reiter, G. Engelich, T. Lahaye, S. Kreil, K. Merx, M.C. Müller, R. Hehlma… , 2002. - 17 S.
In: Der Internist, ISSN 1432-1289. 43(2002), 10, Seite 1228-1244
DOI: 10.1007/s00108-002-0706-6
Merx, Kirsten: Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α / K. Merx, M.C. Müller, S. Kreil, T. Lahaye, P. Paschka, C. Schoch, A. Weisser, C. Kuhn, U. Berger, H.… , 30 August 2002. - 5 S.
In: Leukemia, ISSN 1476-5551. 16(2002), 9, Seite 1579-1583
DOI: 10.1038/sj.leu.2402680
Müller, Martin Christian: Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization / M.C. Müller, K. Merx, A. Weiβer, S. Kreil, T. Lahaye, R. Hehlmann, A. Hochhaus, 26 November 2002. - 5 S.
In: Leukemia, ISSN 1476-5551. 16(2002), 12, Seite 2395-2399
DOI: 10.1038/sj.leu.2402734
Fuente, Josu de la: ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia / Josu de la Fuente, Kirsten Merx, E. Joanna Steer, Martin Müller, Richard M. Szydlo, Ole Maywald, Ute… , November 1, 2001. - 2 S.
In: Blood, ISSN 1528-0020. 98(2001), 9, Seite 2879-2880
DOI: 10.1182/blood.V98.9.2879
Merx, Kirsten: Ergebnisse hämostaseologischer Laboruntersuchungen in Relation zum Therapieerfolg bei Patienten mit tiefer Venenthrombose und Behandlung mit niedermolekularem Heparin oder unfraktioniertem Heparin im Rahmen einer europäischen, multizentrischen, prospektiven, randomisierten klinischen Studie / vorgelegt von Kirsten Merx, 2000. - 90 Bl. : Bl.

IDs

GND:

122413091

Links

Merx, Kirsten in ...

Export Publikationsliste

heiBIB

Bei fehlerhaften oder unvollständigen Angaben wenden Sie sich bitte an biblio@ub.uni-heidelberg.de.

Informationen zu heiBIB (inkl. Einbettung der Publikationslisten in eigene WWW-Seiten).

Impressum / Datenschutz Design